Boehringer Ingelheim: all 2,305 studies
Page 10 of 24. Open to participants first (62), then studies with results posted, then the rest; newest registration first within each.
- Survey on Long-Term Use of BI-Sifrol® Tablets in Patients With Restless Legs SyndromeCompletedNCT01174459Results posted
- Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma IICompletedNCT01172821Phase 3Results posted
- Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma ICompletedNCT01172808Phase 3Results posted
- Safety and Effect of Mirapex(Pramipexole) Tablet Among Korean RLSCompletedNCT01170091Results posted
- Roll Over Study From 1199.30 BIBF 1120 in Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT01170065Phase 2Results posted
- BIBW 2992 (Afatinib) in Combination With Pemetrexed in Advanced Solid TumoursCompletedNCT01169675Phase 1Results posted
- Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 DiabetesCompletedNCT01167881Phase 3Results posted
- Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal ImpairmentCompletedNCT01164501Phase 3Results posted
- Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 DiabetesCompletedNCT01159600Phase 3Results posted
- Relative Bioavailability of Olodaterol and FluconazoleCompletedNCT01153724Phase 1Results posted
- Relative Bioavailability of of Olodaterol and KetoconazoleCompletedNCT01153711Phase 1Results posted
- Pradaxa (Dabigatran Etexilate) VTE Prevention After Elective Total Hip or Knee Replacement SurgeryTerminatedNCT01153698Results posted
- A Randomised, Double- Blind, Placebo Controlled, Cross-over Efficacy and Safety Comparison of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for Four Weeks in Patients With Moderate Persistent AsthmaCompletedNCT01152450Phase 2Results posted
- A Study of BIBW 2992 (Afatinib) in Patients With Metastatic Colorectal CancerCompletedNCT01152437Phase 2Results posted
- BI 6727 (Volasertib) Human ADME Trial in Various Solid TumoursCompletedNCT01145885Phase 1Results posted
- Drug Use Survey of RESPIMAT in Patients With COPDCompletedNCT01145053Results posted
- Prevention of Venous Thromboembolic Events After Elective Orthopaedic Surgery in Patients Treated With PRADAXACompletedNCT01139658Results posted
- A Dose Response Study of Dabigatran Etexilate(BIBR 1048) in Pharmacodynamics and Safety in Patients With Non-valvular Atrial Fibrillation in Comparison to WarfarinCompletedNCT01136408Phase 2Results posted
- Safety and PK Study of BIBF 1120 in Japanese Patients With IPFCompletedNCT01136174Phase 2Results posted
- Non-interventional Observational Study With Viramune® in HIV to Evaluate Gender Specific DataCompletedNCT01134939Results posted
- TElmisartan and AMlodipine Single Pill sTudy With Patients Not on Goal With Mono rAas Therapy-switchCompletedNCT01134393Phase 3Results posted
- Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 InfectionCompletedNCT01132313Phase 2Results posted
- BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).CompletedNCT01131676Phase 3Results posted
- Comparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary DiseaseCompletedNCT01126437Phase 3Results posted
- LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin TreatmentCompletedNCT01125566Phase 3Results posted
- Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate AsthmaCompletedNCT01122680Phase 2Results posted
- BI 6727 (Volasertib) Randomised Trial in Ovarian CancerCompletedNCT01121406Phase 2Results posted
- BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC)CompletedNCT01121393Phase 3Results posted
- Bioequivalence of Pramipexole Extended Release (PPX ER) 1.5mg x 1 Tablet Once Daily (q.d.) vs. PPX ER 0.375mg x 4 Tablets Under Fasted and Fed Conditions in Japanese Healthy VolunteersCompletedNCT01119443Phase 1Results posted
- Drug Drug Interaction of Empagliflozin (BI 10773) and Warfarin in Healthy VolunteersCompletedNCT01111331Phase 1Results posted
- Pharmacokinetics of Empagliflozin (BI 10773) in Patients With Impaired Liver FunctionCompletedNCT01111318Phase 1Results posted
- Evaluation of the Effect of Telmisartan on Blood Pressure Control of High Risk PatientsCompletedNCT01108809Results posted
- Additional Effect of A Life Style Program on Antihypertensive Treatment With TelmisartanCompletedNCT01108796Results posted
- An Eight-week Randomized,Double-blind Study to Evaluate the Efficacy and Safety of Fixed-dose Combinations of T80+A5 Versus A5 Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With A5 MonotherapyCompletedNCT01103960Phase 3Results posted
- BI 671800 in Asthmatic Patients on Inhaled CorticosteroidsCompletedNCT01103349Phase 2Results posted
- Kinetic Tremor in Parkinsons Disease: Its Course Under Pramipexole (Mirapexin®) Treatment and Impact on Quality of LifeCompletedNCT01100073Results posted
- Influence of Pramipexole Extended Release on Medication Adherence in Parkinson´s DiseaseCompletedNCT01097421Results posted
- BI 671800 ED in Steroid-naive Asthmatic PatientsCompletedNCT01092143Phase 2Results posted
- Bi 671800 in Asthmatic Patients on Inhaled CorticosteroidsCompletedNCT01090024Phase 2Results posted
- Trial of BIBW 2992 (Afatinib) + Cetuximab in Non-Small Cell Lung CancerCompletedNCT01090011Phase 1Results posted
- Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal ImpairmentCompletedNCT01087502Phase 3Results posted
- LUX-Lung 5: Afatinib Plus Weekly Paclitaxel Versus Investigator's Choice of Single Agent Chemotherapy Following Afatinib Monotherapy in Non-small Cell Lung Cancer Patients Failing Erlotinib or GefitinibCompletedNCT01085136Phase 3Results posted
- Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 DiabetesCompletedNCT01084005Phase 3Results posted
- Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of AgeCompletedNCT01083732Phase 2Results posted
- Effects of Tiotropium on Breathing Capacity and Exercise Limitation in Early Stages of Chronic Obstructive Pulmonary DiseaseCompletedNCT01072396Phase 4Results posted
- Assessment of the Safety and Efficacy of Pramipexole Extended Release in Patients With Parkinson's Disease in Routine Clinical PracticeCompletedNCT01061567Results posted
- Post-Marketing Surveillance of Micombi Tablets Survey on the Long-term UseCompletedNCT01050062Results posted
- Effect of Treatment BI 1744 CL (5 and 10 mcg) Versus Placebo on Exercise Endurance Time During Constant Work Rate Cycle Ergometry IICompletedNCT01040793Phase 3Results posted
- A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT01040728Phase 3Results posted
- Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT01040689Phase 3Results posted
- Determining Optimal Free Dose Combination of Tiotropium Bromide and BI 1744 CL in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01040403Phase 2Results posted
- Effect of Treatment BI 1744 CL (5 and 10 mcg) Versus Placebo on Exercise Endurance Time During Constant Work Rate Cycle Ergometry ICompletedNCT01040130Phase 3Results posted
- Assessment of Chronic Obstructive Pulmonary Disease (COPD) Therapy From the Physicians Perspective Using Tiotropium as an ExampleCompletedNCT01036763Results posted
- Compare Safety and Efficacy of BIBF 1120 Versus Sunitinib.CompletedNCT01024920Phase 2Results posted
- Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial CancerCompletedNCT01023958Phase 2Results posted
- Combination of BI6727 (Volasertib) and BIBF1120 in Solid TumorsCompletedNCT01022853Phase 1Results posted
- Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT01019694Phase 3Results posted
- LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian CancerCompletedNCT01015118Phase 3Results posted
- A Study of the Safety and Efficacy of 4 Doses of BI 1744 CL Delivered Via the Respimat in Patients With Asthma.CompletedNCT01013753Phase 2Results posted
- Linagliptin 2.5 mg Twice Daily Versus 5 mg Once Daily as add-on Therapy to Twice Daily Metformin in Type 2 DiabetesCompletedNCT01012037Phase 2Results posted
- Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 DiabetesCompletedNCT01011868Phase 2Results posted
- Spiriva Observational Study Measuring Saint George's Respiratory Questionnaire (SGRQ) in Routine Medical Practice in Central & Eastern European RegionCompletedNCT01006135Results posted
- Phase I/II Comparison of Efficacy and Safety of BIBF 1120 and Sorafenib in Patients With Advanced Hepatocellular CarcinomaCompletedNCT01004003Phase 2Results posted
- A Phase II Trial of Afatinib(BIBW 2992) in Third-line Treatment for Patients With Stage IIIB/IV Adenocarcinoma of the Lung Harbouring Wild-type Epidermal Growth Factor Receptor[EGFR]CompletedNCT01003899Phase 2Results posted
- Phase I Dose Escalation Study of Concomitant BIBF 1120 and BIBW 2992 in Patients With Advanced Solid Tumours.CompletedNCT00998296Phase 1Results posted
- Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With PioglitazoneCompletedNCT00996658Phase 3Results posted
- Trial of Continuous Once Daily Oral Treatment Using BIBW 2992 (Afatinib) Plus Sirolimus (Rapamune®) in Patients With Non-small Cell Lung Cancer Harbouring an EGFR Mutation and/or Disease Progression Following Prior Erlotinib or GefitinibCompletedNCT00993499Phase 1Results posted
- A Phase I / II Trial of Nintedanib in Asian Hepatocellular Carcinoma PatientsCompletedNCT00987935Phase 2Results posted
- Short Term Treatment With BI 201335, Peginterferon-alpha 2a and Ribavirin in Hepatitis c Virus Genotype-1 Treatment-naïve Patients (SILEN-C3)CompletedNCT00984620Phase 2Results posted
- An Observational Cohort Study to Evaluate the Safety and Efficacy of Micardis Tablets Taken Once Daily at 40 mg/Day and 80 mg/Day in Hypertensive Patients Under Real Life Conditions in Usual Clinical PracticeCompletedNCT00982735Results posted
- BIBF 1120 in Combination With Pemetrexed in Advanced Non Small Cell Lung Cancer (NSCLC)TerminatedNCT00979576Phase 1Results posted
- Non-interventional Observational Study With Viramune (Nevirapine) and Various Drug Combinations in the Antiretroviral Combination Treatment of HIV-infected Patients Who Have Already Been Treated for Approx. 10 Years With ViramuneCompletedNCT00979420Results posted
- Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma MultiformCompletedNCT00977431Phase 1Results posted
- A Post Marketing Surveillance Study Assessing the Long-term Efficacy and Safety of Aptivus Co-administered With Low-dose Ritonavir in Treatment Experienced Patients With HIV-1 Infection in the Daily Clinical Practice.CompletedNCT00976950Results posted
- Inhaled Corticosteroid Withdrawal in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00975195Phase 4Results posted
- BI 6727 (Volasertib) in Combination With Cisplatin or Carboplatin in Patients With Advanced or Metastatic Solid TumourCompletedNCT00969761Phase 1Results posted
- Dose Finding Study of BI 6727 (Volasertib) in Patients With Various Solid CancersCompletedNCT00969553Phase 1Results posted
- Study to Evaluate the Safety and Efficacy of Pradaxar for the Prevention of Venous Thromboembolism in the Mexican Population Undergoing Elective Total Hip or Knee Replacement SurgeryTerminatedNCT00967447Results posted
- Efficacy and Safety of Linagliptin in Combination With Insulin in Patients With Type 2 DiabetesCompletedNCT00954447Phase 3Results posted
- Phase I Open Label Trial to Assess Safety of BIBW 2992 (Afatinib) in Combination With Herceptin® in Patients With HER2-positive Advanced Breast Cancer.CompletedNCT00950742Phase 1Results posted
- BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR MutationCompletedNCT00949650Phase 3Results posted
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 201335 as Softgel Capsule in Naive Hepatitis C Virus (HCV) PatientsCompletedNCT00947349Phase 2Results posted
- PRO-POWER: Hypertension With Risk Factors for a Duration of 24 Weeks With Micardis 80mg/Micardis Plus 80mg/12.5mgCompletedNCT00936208Results posted
- Pharmacokinetics and Pharmacodynamics Trial With Linagliptin (BI 1356) 5mg in African American Type 2 Diabetic PatientsCompletedNCT00935220Phase 1Results posted
- (Hyoscine Butylbromide) for Abdominal Pain Associated With Cramping on Demand BasisCompletedNCT00932737Phase 2Results posted
- Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00932646Phase 3Results posted
- Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00931385Phase 3Results posted
- Actuation Indicator Trial in Patients With COPDCompletedNCT00928746Phase 3Results posted
- Efficacy (Bronchoprotection) and Safety of Orally Inhaled BI 1744 CL in Patients With Intermittent AsthmaCompletedNCT00928668Phase 2Results posted
- Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe HypertensionCompletedNCT00926289Phase 4Results posted
- Treatment of Type 2 Diabetes With Linagliptin 2.5 mg Bid + Metformin 500 or 1000 mg Bid and Metformin 1000 mg BidCompletedNCT00915772Phase 3Results posted
- Telmisartan 80mg+Hydrochlorothiazide (HCTZ) 25 mg in Hypertension: an Observational StudyCompletedNCT00909038Results posted
- Afatinib and Vinorelbine in Tumours Known to Overexpress EGFR and/or HER2CompletedNCT00906698Phase 1Results posted
- 4 Week Combination of BI 207127 NA With Peg-IFN and Ribavirin in Chronic HCV PatientsCompletedNCT00905632Phase 1Results posted
- A Phase I Multiple Dose Pharmacokinetic Study of Nevirapine Extended Release (XR) in HIV-1 Infected Children.CompletedNCT00905489Phase 1Results posted
- BIBF 1120 Versus Bevacizumab in Metastatic Colorectal CancerCompletedNCT00904839Phase 2Results posted
- Evaluation of the Effect of Telmisartan (Micardis® 80 mg/ MicardisPlus® 80/12.5 mg) on Blood Pressure and Cardiovascular Risk Factor Index in High Risk Hypertensive PatientsCompletedNCT00904371Results posted
- An Observational Study to Investigate the Efficacy, Safety, Tolerability and the Effect on Quality of Life of Telmisartan (Micardis) and Telmisartan With HCTZ (Micardis Plus) in Patients With HypertensionCompletedNCT00904215Results posted
- Telmisartan Tab HypertensionCompletedNCT00890084Results posted
- Non-interventional Observational Study on the Influence of Pramipexole on Sensory Symptoms of Restless Legs Syndrome (RLS)CompletedNCT00887289Results posted